医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Asahi Kasei Medical Bioprocess Affiliate Opens in China

2021年04月21日 AM11:00
このエントリーをはてなブックマークに追加


 

SHANGHAI

Asahi Kasei Medical announces that an affiliated company in China, Asahi Kasei Bioprocess (Shanghai) Co., Ltd. (AKBC), started business on April 1, 2021.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210420005627/en/

Planova™ virus removal filters (Photo: Business Wire)

Planova™ virus removal filters (Photo: Business Wire)

Asahi Kasei Medical is the global market leader in virus filtration, with its Planova™ filters having an unrivaled 30-year history of trusted use in the production of biotherapeutics. We aim to provide “Assurance Beyond Expectation” to ensure product safety and manufacturing efficiency for therapeutics within the biopharmaceutical industry in the form of innovative yet exceptionally reliable purification consumables, equipment and support services.

The global COVID-19 pandemic has increased demand for Planova™ filters as pharmaceutical companies rapidly develop and mass-produce anti-coronavirus agents. Asahi Kasei Medical continues to reinforce its global supply infrastructure for Planova™ in order to support the early provision of coronavirus vaccines and therapies to as many people as possible.

The launch of AKBC facilitates business expansion in China by localizing inventory management and order processing for shorter delivery times while enabling settlement denominated in Chinese yuan. AKBC will also provide deep technical advice and support as well as hands-on training to enable local customers to use the products with greater ease.

Asahi Kasei Medical contributes to life and living for people around the world as a member of the Asahi Kasei Group’s Health Care Sector, enabling biologics manufacturers to safely and efficiently produce medicines that patients can trust.

Corporate Profile of Asahi Kasei Bioprocess (Shanghai) Co., Ltd.

Location:

999 Huaihai Road, Huai Hai Lu Xi Duan, Xuhui District, Shanghai, China

President:

Weichao Zhu

Business content:

  • Import and sale of Planova™ virus removal filters and bioprocess related products and provision of related technical support
  • Provision of technical support related to bioprocess equipment

Establishment:

August 2020 (operation started in April 2021)

Shareholder:

Asahi Kasei (China) Co., Ltd. 100%

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20210420005627/en/

CONTACT

For more information, please contact:

Ryo Kobayashi

Corporate Communications

Asahi Kasei Corp.

Phone: +81-(0)3-6699-3008

Related Posts Plugin for WordPress, Blogger...

同じカテゴリーの記事 

  •  Celltrion’s monoclonal antibody treatment for COVID-19, regdanvimab (CT-P59) becomes the first authorized COVID-19 treatment approved from the Korean Ministry of Food and Drug Safety (MFDS)
  • ENHERTU® Reduced the Risk of Disease Progression or Death by 72% Versus Trastuzumab Emtansine (T-DM1) in Patients with HER2 Positive Metastatic Breast Cancer
  • ENHERTU® Demonstrated Clinically Meaningful and Durable Response in Patients with HER2 Positive Advanced Gastric Cancer in DESTINY-Gastric02 Phase 2 Trial
  • 武田的EXKIVITY™ (mobocertinib)成为美国FDA首次核准的专为EGFR外显子20插入+ NSCLC患者设计的口服治疗药物
  • Masimo上市单例患者使用的rainbow® SuperSensor™